“We want to cooperate with the coronavirus immunisation of this brother country’s people, who suffer the consequences of the U.S. blockade,” Cuban scientists stated.
On Saturday, Cuba’s Center for Genetic Engineering and Biotechnology (CIGB) announced the delivery of 1,5 million Abdala COVID-19 vaccines to Venezuela.
“We want to cooperate with the coronavirus immunization of this brother country’s people, who currently suffer the consequences of the U.S. blockade amidst the pandemic,” the CIGB tweeted and recalled that other 5,4 million Abdala vaccines had previously been shipped to Venezuela.
This vaccine, which proved to have a 92,28 percent efficacy in clinical trials, has been widely used in this Caribbean country’s mass immunization campaign and is currently being analyzed by the World Health Organization (WHO) for its possible international certification.
So far, Cuban scientists have developed two other COVID-19 vaccines: the Sovereign 02 and the Sovereign Plus, which is the only vaccine in the world designed for disease convalescents. In addition, while the Finlay Vaccine Institute (IFV) currently works in the Mambisa vaccine, the CIGB develops the Sovereign 01 vaccine.
“We want to cooperate with the coronavirus immunization of this brother country’s people, who suffer the consequences of the U.S. blockade,” Cuban scientists stated.
On Saturday, Cuba’s Center for Genetic Engineering and Biotechnology (CIGB) announced the delivery of 1,5 million Abdala COVID-19 vaccines to Venezuela.
“We want to cooperate with the coronavirus immunization of this brother country’s people, who currently suffer the consequences of the U.S. blockade amidst the pandemic,” the CIGB tweeted and recalled that other 5,4 million Abdala vaccines had previously been shipped to Venezuela.
This vaccine, which proved to have a 92,28 percent efficacy in clinical trials, has been widely used in this Caribbean country’s mass immunization campaign and is currently being analyzed by the World Health Organization (WHO) for its possible international certification.
So far, Cuban scientists have developed two other COVID-19 vaccines: the Sovereign 02 and the Sovereign Plus, which is the only vaccine in the world designed for disease convalescents. In addition, while the Finlay Vaccine Institute (IFV) currently works in the Mambisa vaccine, the CIGB develops the Sovereign 01 vaccine.
Source: TeleSur
